Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Samad Hosseini"'
Autor:
Samad Hosseini, Abbas Yazdani
Publikováno v:
Journal of Philosophical Investigations, Vol 15, Iss 37, Pp 607-626 (2021)
The undeniable success of neuroscience in explaining human mental states, which in the past were explained in terms of supernatural concepts, has led many modern-day scientists and philosophers to advocate physicalist methods in explaining human natu
Externí odkaz:
https://doaj.org/article/bcf4947f078946c5a9c7e82daa53169e
Autor:
Nazila Mozammel, Elham Baghbani, Mohammad Amini, Sheyda Jodeiry Zaer, Yalda Baghay Esfandyari, Maryam Tohidast, Seyed Samad Hosseini, Seyed Ali Rahmani, Ahad Mokhtarzadeh, Behzad Baradaran
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 14, Iss 1, Pp 231-240 (2024)
Purpose: MicroRNAs (miRNAs) are a group of small regulatory non-coding RNAs, which are dysregulated through tumor progression. let-7 and MIR-145 are both tumor suppressor microRNAs that are downregulated in a wide array of cancers including colorecta
Externí odkaz:
https://doaj.org/article/7374291aa6f3442fbbbe20da9faab324
Autor:
Maryam Tohidast, Neda Memari, Mohammad Amini, Seyed Samad Hosseini, Asiyeh Jebelli, Mohammad Amin Doustvandi, Behzad Baradaran, Ahad Mokhtarzadeh
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 26, Iss 11, Pp 1350-1359 (2023)
Objective(s): Prostate cancer (PC) is one of the most commonly diagnosed malignancies among men worldwide. Paclitaxel is a chemotherapeutic agent widely used to treat different types of cancer. Recent studies revealed miRNAs control various genes tha
Externí odkaz:
https://doaj.org/article/c94e7686b69a452585263045e7585f05
Autor:
Sheyda Jodeiry Zaer, Mahmoudreza Aghamaali, Mohammad Amini, Mohammad Amin Doustvandi, Seyed Samad Hosseini, Behzad Baradaran, Souzan Najafi, Yalda Baghay Esfandyari, Ahad Mokhtarzadeh
Publikováno v:
BioImpacts, Vol 14, Iss 3, Pp 29913-29913 (2024)
Introduction: As the most common aggressive primary brain tumor, glioblastoma is inevitably a recurrent malignancy whose patients’ prognosis is poor. miR-143 and miR-145, as tumor suppressor miRNAs, are downregulated through tumorigenesis of multip
Externí odkaz:
https://doaj.org/article/f582d45a55a84cd79224846d3e58273a
Autor:
Farzaneh Bilan, Mohammad Amini, Mohammad Amin Doustvandi, Maryam Tohidast, Amir Baghbanzadeh, Seyed Samad Hosseini, Ahad Mokhtarzadeh, Behzad Baradaran
Publikováno v:
BioImpacts, Vol 14, Iss 2, Pp 27764-27764 (2024)
Introduction: Gastric cancer (GC) is the third leading cause of cancer-related death worldwide. microRNAs are a group of regulatory non-coding RNAs that are involved in GC progression. miR-145 as a tumor suppressor and miR-21 as an oncomiR were shown
Externí odkaz:
https://doaj.org/article/d0ee13dae9b64b15a834986becb7ad92
Autor:
Samad Hosseini, Seyed, Jebelli, Asiyeh, Vandghanooni, Somayeh, Jahanban-Esfahlan, Ali, Baradaran, Behzad, Amini, Mohammad, Bidar, Negar, de la Guardia, Miguel, Mokhtarzadeh, Ahad, Eskandani, Morteza
Publikováno v:
In Chemical Engineering Journal 1 August 2022 441
Publikováno v:
مطالعات منابع انسانی, Vol 9, Iss 4, Pp 123-144 (2020)
Background & Purpose: Knowledge sharing is a prerequisite for the acquisition of competitive advantage and sustainable innovation. At the same time, the effective adaptability of an organization depends on the ability to adapt to all business element
Externí odkaz:
https://doaj.org/article/4f04072558df482e84a6a41c7d208813
Publikováno v:
In Journal of Drug Delivery Science and Technology June 2018 45:240-254
Autor:
Seyed Samad Hosseini, Mojtaba Alishahi, Kourosh Amini, Masoud Ghorbanpour, Takavar Mohammadian
Publikováno v:
Aquaculture International. 30:3247-3268
Autor:
Negar Bidar, Saeed Khalili, Michael R. Hamblin, Mohammad-Ali Shahbazi, Jafar Mosafer, Mahmoud Hashemzaei, Behzad Baradaran, Ahad Mokhtarzadeh, Seyed Samad Hosseini
Publikováno v:
International Journal of Biological Macromolecules. 167:1030-1047
Bispecific antibodie (BsAbs) combine two or more epitope-recognizing sequences into a single protein molecule. The first therapeutic applications of BsAbs were focused on cancer therapy. However, these antibodies have grown to cover a wider disease s